304 related articles for article (PubMed ID: 33220521)
1. Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies.
Sturchio A; Gastaldi M; Cariddi LP; Biacchi D; Espay AJ; Franciotta D; Versino M; Mauri M
Parkinsonism Relat Disord; 2021 Jan; 82():7-9. PubMed ID: 33220521
[No Abstract] [Full Text] [Related]
2. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.
Ali F; Wijdicks EF
Neurocrit Care; 2020 Feb; 32(1):286-294. PubMed ID: 31732848
[TBL] [Abstract][Full Text] [Related]
3. A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon.
Degeneffe A; Dagonnier M; D'hondt A; Elosegi JA
BMC Neurol; 2018 Oct; 18(1):173. PubMed ID: 30336789
[TBL] [Abstract][Full Text] [Related]
4. Glycine Receptor β-Targeting Autoantibodies Contribute to the Pathology of Autoimmune Diseases.
Wiessler AL; Talucci I; Piro I; Seefried S; Hörlin V; Baykan BB; Tüzün E; Schaefer N; Maric HM; Sommer C; Villmann C
Neurol Neuroimmunol Neuroinflamm; 2024 Mar; 11(2):e200187. PubMed ID: 38215349
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric Presentation of Anti-DPPX Progressive Encephalomyelitis with Rigidity and Myoclonus.
Neo RJ; Mehta AR; Weston M; Magrinelli F; Quattrone A; Gandhi S; Joyce EM; Bhatia KP
Mov Disord Clin Pract; 2024 Jan; 11(1):97-100. PubMed ID: 38291842
[No Abstract] [Full Text] [Related]
6. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.
Varley J; Vincent A; Irani SR
J Neurol; 2015; 262(4):1081-95. PubMed ID: 25491076
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and translational research.
Dinter E; Saridaki T; Diederichs L; Reichmann H; Falkenburger BH
Transl Neurodegener; 2020 Dec; 9(1):43. PubMed ID: 33256849
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease and skin.
Niemann N; Billnitzer A; Jankovic J
Parkinsonism Relat Disord; 2021 Jan; 82():61-76. PubMed ID: 33248395
[TBL] [Abstract][Full Text] [Related]
9. Hot Topic: Epigenetics in Parkinson's Disease: A New Frontier for Disease-Modifying Therapies.
Portley MK; Scholz SW
Mov Disord; 2021 Apr; 36(4):862. PubMed ID: 33245171
[No Abstract] [Full Text] [Related]
10. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Dewan R; Chia R; Ding J; Hickman RA; Stein TD; Abramzon Y; Ahmed S; Sabir MS; Portley MK; Tucci A; Ibáñez K; Shankaracharya FNU; Keagle P; Rossi G; Caroppo P; Tagliavini F; Waldo ML; Johansson PM; Nilsson CF; ; ; ; ; ; ; ; ; Rowe JB; Benussi L; Binetti G; Ghidoni R; Jabbari E; Viollet C; Glass JD; Singleton AB; Silani V; Ross OA; Ryten M; Torkamani A; Tanaka T; Ferrucci L; Resnick SM; Pickering-Brown S; Brady CB; Kowal N; Hardy JA; Van Deerlin V; Vonsattel JP; Harms MB; Morris HR; Ferrari R; Landers JE; Chiò A; Gibbs JR; Dalgard CL; Scholz SW; Traynor BJ
Neuron; 2021 Feb; 109(3):448-460.e4. PubMed ID: 33242422
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
Al-Qassabi A; Tsao TS; Racolta A; Kremer T; Cañamero M; Belousov A; Santana MA; Beck RC; Zhang H; Meridew J; Pugh J; Lian F; Robida MD; Ritter M; Czech C; Beach TG; Pestic-Dragovich L; Taylor KI; Zago W; Tang L; Dziadek S; Postuma RB
Mov Disord; 2021 Apr; 36(4):895-904. PubMed ID: 33232556
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal features of β-γ phase-amplitude coupling in Parkinson's disease derived from scalp EEG.
Gong R; Wegscheider M; Mühlberg C; Gast R; Fricke C; Rumpf JJ; Nikulin VV; Knösche TR; Classen J
Brain; 2021 Mar; 144(2):487-503. PubMed ID: 33257940
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy.
Merello M; Bhatia KP; Obeso JA
Lancet Neurol; 2021 Feb; 20(2):94-95. PubMed ID: 33253627
[No Abstract] [Full Text] [Related]
14. Is Levodopa Response a Valid Indicator of Parkinson's Disease?
Martin WRW; Miles M; Zhong Q; Hartlein J; Racette BA; Norris SA; Ushe M; Maiti B; Criswell S; Davis AA; Kotzbauer PT; Cairns NJ; Perrin RJ; Perlmutter JS
Mov Disord; 2021 Apr; 36(4):948-954. PubMed ID: 33253432
[TBL] [Abstract][Full Text] [Related]
15. TRIM3 attenuates apoptosis in Parkinson's disease via activating PI3K/AKT signal pathway.
Dong W; Luo B; Qiu C; Jiang X; Shen B; Zhang L; Liu W; Zhang W
Aging (Albany NY); 2020 Nov; 13(1):735-749. PubMed ID: 33253119
[TBL] [Abstract][Full Text] [Related]
16. Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease.
Zhang JN; Huang YL; Yang HM; Wang Y; Gu L; Zhang H
Mol Cell Neurosci; 2021 Jan; 110():103572. PubMed ID: 33248235
[TBL] [Abstract][Full Text] [Related]
17. Levodopa-Induced Dyskinesia Are Mediated by Cortical Gamma Oscillations in Experimental Parkinsonism.
Güttler C; Altschüler J; Tanev K; Böckmann S; Haumesser JK; Nikulin VV; Kühn AA; van Riesen C
Mov Disord; 2021 Apr; 36(4):927-937. PubMed ID: 33247603
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies.
Palleis C; Sauerbeck J; Beyer L; Harris S; Schmitt J; Morenas-Rodriguez E; Finze A; Nitschmann A; Ruch-Rubinstein F; Eckenweber F; Biechele G; Blume T; Shi Y; Weidinger E; Prix C; Bötzel K; Danek A; Rauchmann BS; Stöcklein S; Lindner S; Unterrainer M; Albert NL; Wetzel C; Rupprecht R; Rominger A; Bartenstein P; Herms J; Perneczky R; Haass C; Levin J; Höglinger GU; Brendel M
Mov Disord; 2021 Apr; 36(4):883-894. PubMed ID: 33245166
[TBL] [Abstract][Full Text] [Related]
19. α-Lipoic acid alleviates ferroptosis in the MPP
Liu L; Yang S; Wang H
Cell Biol Int; 2021 Feb; 45(2):422-431. PubMed ID: 33241887
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.
Liu T; Zhang Y; Liu W; Zhao J
Neurochem Res; 2021 Feb; 46(2):230-240. PubMed ID: 33241432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
